{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:22:52Z","timestamp":1791339772482,"version":"4.3.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vascn.2009.11.002","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T05:11:54Z","timestamp":1260162714000},"page":"287-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Optimization of ferric chloride induced thrombosis model in rats: Effect of anti-platelet and anti-coagulant drugs"],"prefix":"10.1016","volume":"61","author":[{"given":"W.R.","family":"Surin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.K.","family":"Barthwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.vascn.2009.11.002_bib1","first-page":"55","article-title":"Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?","volume":"26","author":"Andre","year":"1996","journal-title":"Haemostasis"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/84667","article-title":"Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis","volume":"7","author":"Angelillo-Scherrer","year":"2001","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0049-3848(97)00308-3","article-title":"Comparison of the antithrombotic effects of FK633, GPIIb\/IIIa antagonist, and aspirin in a guinea pig thrombosis model","volume":"89","author":"Aoki","year":"1998","journal-title":"Thrombosis Research"},{"issue":"1","key":"10.1016\/j.vascn.2009.11.002_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrd985","article-title":"Scientific and therapeutic advances in antiplatelet therapy","volume":"2","author":"Bhatt","year":"2003","journal-title":"Nature Reviews Drug Discovery"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.STR.20.4.441","article-title":"A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study","volume":"20","author":"Biller","year":"1989","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.vascn.2009.11.002_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.thromres.2008.03.010","article-title":"Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis","volume":"123","author":"Bird","year":"2008","journal-title":"Thrombosis Research"},{"key":"10.1016\/j.vascn.2009.11.002_bib8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2741\/1800","article-title":"Blood clotting, inflammation, and thrombosis in cardiovascular events: perspectives","volume":"11","author":"Boos","year":"2006","journal-title":"Frontiers Biosciences"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0049-3848(91)90341-S","article-title":"The effect of thrombin inhibition in a rat arterial thrombosis model","volume":"64","author":"Broersma","year":"1991","journal-title":"Thrombosis Research"},{"issue":"7","key":"10.1016\/j.vascn.2009.11.002_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1101\/gad.9.7.794","article-title":"Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction","volume":"9","author":"Bugge","year":"1995","journal-title":"Genes & Development"},{"issue":"28","key":"10.1016\/j.vascn.2009.11.002_bib11","doi-asserted-by":"crossref","first-page":"16886","DOI":"10.1074\/jbc.270.28.16886","article-title":"The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility","volume":"270","author":"Bugge","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.vascn.2009.11.002_bib66","doi-asserted-by":"crossref","unstructured":"CAPRIE Steering Committee. (1996). A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348(9038), 1329\u20131339.","DOI":"10.1016\/S0140-6736(96)09457-3"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib12","first-page":"761","article-title":"Vascular wound healing and neointima formation induced by perivascular electric injury in mice","volume":"150","author":"Carmeliet","year":"1997","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/187152507781058717","article-title":"Advances in antithrombotic agents","volume":"5","author":"Chakrabarti","year":"2007","journal-title":"Cardiovascular & Hematological Agents in Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.vascn.2009.11.002_bib14","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1182\/blood-2004-03-0935","article-title":"Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation","volume":"104","author":"Chou","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0049-3848(01)00353-X","article-title":"Antiplatelet and antithrombotic activity of RWJ-53308, a novel orally active glycoprotein IIb\/IIIa antagonist","volume":"104","author":"Damiano","year":"2001","journal-title":"Thrombosis Research"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0037-1613739","article-title":"Murine thrombosis models","volume":"92","author":"Day","year":"2004","journal-title":"Thrombosis and Haemostasis"},{"issue":"6","key":"10.1016\/j.vascn.2009.11.002_bib17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.thromres.2005.11.015","article-title":"Arterial antithrombotic effects of aspirin, heparin, enoxaparin and clopidogrel alone, or in combination, in the rat","volume":"118","author":"Daykin","year":"2006","journal-title":"Thrombosis Research"},{"issue":"16","key":"10.1016\/j.vascn.2009.11.002_bib18","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-3848(98)00213-8","article-title":"Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat","volume":"94","author":"Elg","year":"1999","journal-title":"Thrombosis Research"},{"issue":"10","key":"10.1016\/j.vascn.2009.11.002_bib20","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.CIR.97.10.1002","article-title":"Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice","volume":"97","author":"Farrehi","year":"1998","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.vascn.2009.11.002_bib21","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1182\/blood.V93.6.1825.406k37_1825_1830","article-title":"Vitronectin inhibits the thrombotic response to arterial injury in mice","volume":"93","author":"Fay","year":"1999","journal-title":"Blood"},{"issue":"6 Suppl B","key":"10.1016\/j.vascn.2009.11.002_bib22","doi-asserted-by":"crossref","first-page":"159B","DOI":"10.1016\/S0735-1097(86)80017-1","article-title":"Disseminated intravascular coagulation","volume":"8","author":"Fruchtman","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1016\/j.vascn.2009.11.002_bib23","first-page":"592","article-title":"Mutations in protein C: molecular pathology of thrombosis","volume":"119","author":"Furie","year":"1992","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"issue":"6 Suppl","key":"10.1016\/j.vascn.2009.11.002_bib24","first-page":"IV15","article-title":"Importance of experimental models for the development of clinical trials on thromboatherosclerosis","volume":"83","author":"Fuster","year":"1991","journal-title":"Circulation"},{"issue":"Suppl 2","key":"10.1016\/j.vascn.2009.11.002_bib25","first-page":"S2","article-title":"Coagulation cascade","volume":"10","author":"Green","year":"2006","journal-title":"Hemodialysis International International Symposium on Home Hemodialysis"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.thromres.2007.03.026","article-title":"In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice","volume":"121","author":"Gui","year":"2007","journal-title":"Thrombosis Research"},{"issue":"8","key":"10.1016\/j.vascn.2009.11.002_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group","volume":"321","author":"Hass","year":"1989","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib28","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0092-8674(90)90010-C","article-title":"Neonatal bleeding in transgenic mice expressing urokinase-type plasminogen activator","volume":"62","author":"Heckel","year":"1990","journal-title":"Cell"},{"issue":"2 Suppl","key":"10.1016\/j.vascn.2009.11.002_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1067\/mhj.2001.117031","article-title":"New anticoagulants","volume":"142","author":"Hirsh","year":"2001","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib30","first-page":"635","article-title":"Warfarin therapy: evolving strategies in anticoagulation","volume":"59","author":"Horton","year":"1999","journal-title":"American Family Physician"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1254\/fpj.100.271","article-title":"Thrombus models and mechanisms of action of anti-platelet drugs","volume":"100","author":"Katori","year":"1992","journal-title":"Nippon Yakurigaku Zasshi"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0049-3848(90)90106-M","article-title":"Rat model of arterial thrombosis induced by ferric chloride","volume":"60","author":"Kurz","year":"1990","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1056-8719(00)00095-2","article-title":"Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents","volume":"43","author":"Leadley","year":"2000","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib34","first-page":"537","article-title":"Ultrastructure of a model of thrombogenesis induced by mechanical injury","volume":"13","author":"Le Menn","year":"1981","journal-title":"Journal of Submicroscopic Cytology"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00005344-199905000-00007","article-title":"Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis","volume":"33","author":"Lockyer","year":"1999","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2005.08.001","article-title":"GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism","volume":"118","author":"Lockyer","year":"2006","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib37","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0741-5214(03)01033-4","article-title":"P-selectin and leukocyte microparticles are associated with venous thrombogenesis","volume":"38","author":"Myers","year":"2003","journal-title":"Journal of Vascular Surgery"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.thromres.2007.12.017","article-title":"Obesity promotes injury induced femoral artery thrombosis in mice","volume":"122","author":"Nagai","year":"2008","journal-title":"Thrombosis Research"},{"issue":"5 Suppl","key":"10.1016\/j.vascn.2009.11.002_bib39","doi-asserted-by":"crossref","first-page":"1674S","DOI":"10.1093\/ajcn\/65.5.1674S","article-title":"Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease","volume":"65","author":"Pearson","year":"1997","journal-title":"The Americal Journal of Clinical Nutrition"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib40","first-page":"197","article-title":"Experimental animal models of arterial thrombosis and the screening of platelet-inhibiting, anti-thrombotic drugs: a review","volume":"1","author":"Philp","year":"1979","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib41","first-page":"187","article-title":"Haemostatic factors and coronary heart disease","volume":"36","author":"Pilgeram","year":"1982","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.1016\/j.vascn.2009.11.002_bib42","first-page":"66","article-title":"Uber experimentelle Thrombose und ihre Behandlung mit Heparin","volume":"74","author":"Reimann-Hunziker","year":"1944","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.20050664","article-title":"Defective thrombus formation in mice lacking coagulation factor XII","volume":"202","author":"Renne","year":"2005","journal-title":"The Journal of Experimental Medicine"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2009.11.002_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thromres.2003.08.012","article-title":"Differential effects of sodium nitroprusside and hydralazine in a rat model of topical FeCl3-induced carotid artery thrombosis","volume":"111","author":"Robinson","year":"2003","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib45","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0002-9440(10)64117-X","article-title":"Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi","volume":"158","author":"Rosen","year":"2001","journal-title":"The American Journal of Pathology"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0049-3848(94)90086-8","article-title":"Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells","volume":"73","author":"Savi","year":"1994","journal-title":"Thrombosis Research"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/00005344-199310000-00004","article-title":"Superior activity of a thromboxane receptor antagonist as compared with aspirin in rat models of arterial and venous thrombosis","volume":"22","author":"Schumacher","year":"1993","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0038-1651642","article-title":"Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis","volume":"69","author":"Schumacher","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1016\/j.vascn.2009.11.002_bib49","first-page":"175","article-title":"Development and applications of animal models of thrombosis","volume":"93","author":"Shebuski","year":"2004","journal-title":"Methods in Molecular Medicine"},{"issue":"2\u20133","key":"10.1016\/j.vascn.2009.11.002_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-2999(97)83044-0","article-title":"Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022","volume":"328","author":"Shimazawa","year":"1997","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.vascn.2009.11.002_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0049-3848(88)90184-3","article-title":"Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat","volume":"50","author":"Smith","year":"1988","journal-title":"Thrombosis Research"},{"issue":"7","key":"10.1016\/j.vascn.2009.11.002_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.bjp.0703237","article-title":"The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties","volume":"129","author":"Sugidachi","year":"2000","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.vascn.2009.11.002_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0014-2999(00)00434-9","article-title":"Z-335, a new thromboxane A(2) receptor antagonist, prevents arterial thrombosis induced by ferric chloride in rats","volume":"401","author":"Tanaka","year":"2000","journal-title":"European Journal of Pharmacology"},{"issue":"2\u20133","key":"10.1016\/j.vascn.2009.11.002_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0049-3848(03)00339-6","article-title":"Anti-thrombotic activity of PDR, a newly synthesized L-Arg derivative, on three thrombosis models in rats","volume":"110","author":"Tang","year":"2003","journal-title":"Thrombosis Research"},{"issue":"2","key":"10.1016\/j.vascn.2009.11.002_bib55","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.thromres.2005.09.004","article-title":"Transendothelial migration of ferric ion in FeCl3 injured murine common carotid artery","volume":"118","author":"Tseng","year":"2006","journal-title":"Thrombosis Research"},{"issue":"6","key":"10.1016\/j.vascn.2009.11.002_bib56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1055\/s-0038-1656125","article-title":"Tissue factor expression during monocyte\u2013macrophage differentiation","volume":"77","author":"van den Eijnden","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib57","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1055\/s-0038-1656086","article-title":"Nerme, Abrahamsson T. The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis","volume":"77","author":"van Giezen","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2515\/therapie:2006069","article-title":"Experimental models of thrombosis and atherosclerosis","volume":"61","author":"Verbeuren","year":"2006","journal-title":"Therapie"},{"issue":"4","key":"10.1016\/j.vascn.2009.11.002_bib59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1538-7836.2005.01236.x","article-title":"Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice","volume":"3","author":"Wang","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1\u20132","key":"10.1016\/j.vascn.2009.11.002_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2004.07.009","article-title":"An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research","volume":"115","author":"Wang","year":"2005","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1016\/j.vascn.2009.11.002_bib61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.410170513","article-title":"Induction of reproducible brain infarction by photochemically initiated thrombosis","volume":"17","author":"Watson","year":"1985","journal-title":"Annals of Neurology"},{"issue":"6 Suppl B","key":"10.1016\/j.vascn.2009.11.002_bib62","doi-asserted-by":"crossref","first-page":"10B","DOI":"10.1016\/S0735-1097(86)80003-1","article-title":"Pharmacology of heparin and warfarin","volume":"8","author":"Wessler","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.vascn.2009.11.002_bib63","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1152\/jappl.1959.14.6.943","article-title":"Biologic assay of a thrombosis-inducing activity in human serum","volume":"14","author":"Wessler","year":"1959","journal-title":"Journal of Applied Physiology"},{"issue":"10","key":"10.1016\/j.vascn.2009.11.002_bib64","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/ATVBAHA.107.142810","article-title":"Murine models of vascular thrombosis (Eitzman series)","volume":"27","author":"Westrick","year":"2007","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"26","key":"10.1016\/j.vascn.2009.11.002_bib65","doi-asserted-by":"crossref","first-page":"12426","DOI":"10.1073\/pnas.92.26.12426","article-title":"Vitronectin is not essential for normal mammalian development and fertility","volume":"92","author":"Zheng","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871909003347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871909003347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:55:22Z","timestamp":1761004522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871909003347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1056871909003347"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2009.11.002","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of ferric chloride induced thrombosis model in rats: Effect of anti-platelet and anti-coagulant drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2009.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}